Absci Corp. (ABSI)
8.45
-0.68
(-7.50%)
USD |
NASDAQ |
Nov 13, 16:00
8.47
+0.02
(+0.24%)
After-Hours: 19:59
Absci Net Income (Quarterly) : -33.30M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -33.30M |
| June 30, 2026 | -33.21M |
| March 31, 2026 | -29.60M |
| December 31, 2025 | -29.56M |
| September 30, 2025 | -28.71M |
| June 30, 2025 | -30.57M |
| March 31, 2025 | -26.35M |
| December 31, 2024 | -28.98M |
| September 30, 2024 | -27.40M |
| June 30, 2024 | -24.75M |
| March 31, 2024 | -21.98M |
| December 31, 2023 | -23.54M |
| September 30, 2023 | -21.99M |
| June 30, 2023 | -41.67M |
| Date | Value |
|---|---|
| March 31, 2023 | -23.36M |
| December 31, 2022 | -19.47M |
| September 30, 2022 | -27.26M |
| June 30, 2022 | -28.68M |
| March 31, 2022 | -29.49M |
| December 31, 2021 | -25.17M |
| September 30, 2021 | -23.63M |
| June 30, 2021 | -41.20M |
| March 31, 2021 | -10.96M |
| December 31, 2020 | -4.939M |
| September 30, 2020 | -3.748M |
| June 30, 2020 | -3.008M |
| March 31, 2020 | -2.658M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Twist Bioscience Corp. | -20.62M |
| Moderna, Inc. | 162.00M |
| Tenax Therapeutics, Inc. | -16.70M |
| Exicure, Inc. | -1.121M |
| Recursion Pharmaceuticals, Inc. | -119.04M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.304M |
| Total Expenses (Quarterly) | 33.60M |
| EPS Diluted (Quarterly) | -0.1938 |
| Enterprise Value | 1.286B |
| Gross Profit Margin (Quarterly) | -784.2% |
| Profit Margin (Quarterly) | -10.95K% |
| Earnings Yield | -9.40% |
| Normalized Earnings Yield | -9.683 |